TY - JOUR
T1 - Severe acute respiratory syndrome (SARS) coronavirus-induced lung epithelial cytokines exacerbate SARS pathogenesis by modulating intrinsic functions of monocyte-derived macrophages and dendritic cells
AU - Yoshikawa, Tomoki
AU - Hill, Terence
AU - Li, Kui
AU - Peters, Clarence J.
AU - Tseng, Chien Te K.
PY - 2009/4
Y1 - 2009/4
N2 - Severe acute respiratory syndrome (SARS), which is caused by a novel coronavirus (CoV), is a highly communicable disease with the lungs as the major pathological target. Although SARS likely stems from overexuberant host inflammatory responses, the exact mechanism leading to the detrimental outcome in patients remains unknown. Pulmonary macrophages (MΦ), airway epithelium, and dendritic cells (DC) are key cellular elements of the host innate defenses against respiratory infections. While pulmonary MΦ are situated at the luminal epithelial surface, DC reside abundantly underneath the epithelium. Such strategic locations of these cells within the airways make it relevant to investigate their likely impact on SARS pathogenesis subsequent to their interaction with infected lung epithelial cells. To study this, we established highly polarized human lung epithelial Calu-3 cells by using the Transwell culture system. Here we report that supernatants harvested from the apical and basolateral domains of infected Calu-3 cells are potent in modulating the intrinsic functions of MΦ and DC, respectively. They prompted the production of cytokines by both MΦ and DC and selectively induced CD40 and CD86 expression only on DC. However, they compromised the abilities of the DC and MΦ in priming naive T cells and phagocytosis, respectively. We also identified interleukin-6 (IL-6) and IL-8 as key SARS-CoV-induced epithelial cytokines capable of inhibiting the T-cell-priming ability of DC. Taken together, our results provide insights into the molecular and cellular bases of the host antiviral innate immunity within the lungs that eventually lead to an exacerbated inflammatory cascades and severe tissue damage in SARS patients.
AB - Severe acute respiratory syndrome (SARS), which is caused by a novel coronavirus (CoV), is a highly communicable disease with the lungs as the major pathological target. Although SARS likely stems from overexuberant host inflammatory responses, the exact mechanism leading to the detrimental outcome in patients remains unknown. Pulmonary macrophages (MΦ), airway epithelium, and dendritic cells (DC) are key cellular elements of the host innate defenses against respiratory infections. While pulmonary MΦ are situated at the luminal epithelial surface, DC reside abundantly underneath the epithelium. Such strategic locations of these cells within the airways make it relevant to investigate their likely impact on SARS pathogenesis subsequent to their interaction with infected lung epithelial cells. To study this, we established highly polarized human lung epithelial Calu-3 cells by using the Transwell culture system. Here we report that supernatants harvested from the apical and basolateral domains of infected Calu-3 cells are potent in modulating the intrinsic functions of MΦ and DC, respectively. They prompted the production of cytokines by both MΦ and DC and selectively induced CD40 and CD86 expression only on DC. However, they compromised the abilities of the DC and MΦ in priming naive T cells and phagocytosis, respectively. We also identified interleukin-6 (IL-6) and IL-8 as key SARS-CoV-induced epithelial cytokines capable of inhibiting the T-cell-priming ability of DC. Taken together, our results provide insights into the molecular and cellular bases of the host antiviral innate immunity within the lungs that eventually lead to an exacerbated inflammatory cascades and severe tissue damage in SARS patients.
UR - http://www.scopus.com/inward/record.url?scp=63149161765&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=63149161765&partnerID=8YFLogxK
U2 - 10.1128/JVI.01792-08
DO - 10.1128/JVI.01792-08
M3 - Article
C2 - 19004938
AN - SCOPUS:63149161765
SN - 0022-538X
VL - 83
SP - 3039
EP - 3048
JO - Journal of virology
JF - Journal of virology
IS - 7
ER -